MARSHALL WACE, LLP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$293,604
-91.3%
451,698
-77.0%
0.00%
-85.7%
Q3 2022$3,373,000
+334.1%
1,961,127
+213.0%
0.01%
+250.0%
Q2 2022$777,000
+447.2%
626,531
+379.4%
0.00%
Q4 2021$142,000
-85.0%
130,700
-74.8%
0.00%
-100.0%
Q3 2021$944,000
+667.5%
518,868
+964.1%
0.00%
+300.0%
Q4 2020$123,000
-7.5%
48,763
-7.8%
0.00%0.0%
Q3 2020$133,000
-61.1%
52,881
-49.3%
0.00%
-50.0%
Q2 2020$342,000
-39.6%
104,335
-29.1%
0.00%
-33.3%
Q1 2019$566,000
-21.3%
147,240
-61.7%
0.00%
-57.1%
Q4 2018$719,000
+212.6%
384,016
+435.0%
0.01%
+600.0%
Q3 2018$230,00071,7820.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders